Valeant sets sights on Mideast, North Africa with Amoun purchase
Friday, July 17, 2015 - 08:30
in Mathematics & Economics
Valeant Pharmaceuticals International, Inc. says it will buy a major Egyptian pharmaceutical company for about $800 million US as a platform for further expansion in the Middle East and North Africa.